#415: Neurotech: Accelerating Innovation in a Complex Medical Device Vertical

Global Medical Device Podcast · 14 Jul 2025 · 33m · Episode 415

What this episode covers

Matt Stratton, Director and Principal Consultant at Coalition, discusses the broad scope of neurotechnology and the challenges of accelerating innovation in this highly regulated vertical. He highlights the difficulty of cross-functional collaboration between neuroscientists, engineers, and regulatory experts, as well as the need for a unified industry voice to navigate complex regulatory frameworks and ethical considerations. Stratton emphasizes the importance of community building to share best practices on funding, clinical trials, and regulatory strategy, drawing parallels to the rapid innovation cycles seen in the semiconductor industry.

Other shows on the same ground, closest first.

  • Let's Combinate · 35m

    126 - Combination Products Collaboration, Turnover on MedTech/Pharma Project Teams, and Lessons from working with Intel's CEO with Mat Stratton, Founder of Coalition Ltd

    Mat Stratton, Founder of Coalition Ltd, discusses his 20-year career in MedTech and combination products, highlighting his early work with Intel CEO Andy Grove on deep brain stimulation and drug delivery systems. He explains how the high-speed culture of Intel, driven by Grove's Parkinson's disease advocacy, contrasted with the slow 4-10 year cycles of medical device development. Stratton identifies 'multifunctional collaboration' and employee turnover as key bottlenecks, proposing solutions like 'two-pizza teams' and regulatory stewardship to accelerate progress in highly regulated industries.

  • Being an Engineer · 40m

    S2E40 Voice of the Customer, Using Questions, and the Technology Adoption Life Cycle Curve | Ted Newill

    Ted Newill, founder of Medical Device Success and SRD Vision, discusses the critical importance of 'Voice of the Customer' and the Technology Adoption Life Cycle Curve for medtech startups. He explains how engineers can bridge the gap between regulatory approval and commercialization by identifying early adopters and key opinion leaders before launch. Newill also shares advice on managing the pressure of venture-funded environments and the necessity of empathy and listening when collaborating with marketing and sales teams.

  • Being an Engineer · 47m

    S5E44 Geoff Gaw | Nitinol, R&D, and How to Learn About New Technologies

    Geoff Gaw, a Senior Principal Engineer at Edwards Lifesciences with prior leadership roles at Medtronic and Applied Medical, discusses the unique challenges of working with Nitinol and managing teams in highly regulated medical device environments. He explains how he aligns product development with process development by waiting for clinical viability signals before committing to mass production strategies, and details his approach to scaling engineering teams by leveraging high performers rather than micromanaging. Gaw also shares his perspective on staying current with emerging technologies through job mobility and predicts the integration of AI in medical procedures, noting the associated risks of opacity in decision-making.

  • Being an Engineer · 45m

    S5E7 Matt Zachek | Medical Device Engineering Leaders 7

    Matt Zachek, Senior Director of R&D at Werfen, discusses his career path in medical device engineering, emphasizing the importance of technical foundations, grit, and managing ambiguity. He explains how balancing sustaining products with new R&D efforts requires a strategic portfolio approach, often following a 70-10-10-10 rule. Zachek highlights key industry trends, including the integration of AI tools like Google Gemini for research acceleration and the convergence of consumer electronics with regulated medical devices. He also stresses the value of early manufacturing involvement and in-situ empathy to navigate the complex regulatory landscape of hemostasis and acute care diagnostics.

  • Let's Combinate · 1h 23m

    022 - "What Chapter are you in?" with Susan Neadle

    Susan Neadle, Principal Consultant at Combination Products Consulting Services LLC and former Head of Combination Products at Amgen and Johnson & Johnson, discusses the regulatory and engineering challenges of combination products. She details the implementation of 21 CFR Part 4, the importance of harmonizing terminology between drug and device sectors, and her work with standards bodies like ASTM and AAMI on TIR 48 and TIR 105. Neadle explains her strategic planning frameworks, including the Merlin Exercise and Design to Value, to navigate complex quality systems and global regulatory differences.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.